Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cannabics Pharmaceuticals Inc (CNBX)

Cannabics Pharmaceuticals Inc (CNBX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.37
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1600 +9.06%
on 09/04/20
0.2050 -14.88%
on 08/26/20
-0.0176 (-9.16%)
since 08/18/20
3-Month
0.1600 +9.06%
on 09/04/20
0.3330 -47.60%
on 06/19/20
-0.1039 (-37.32%)
since 06/18/20
52-Week
0.0660 +164.39%
on 12/30/19
0.6100 -71.39%
on 01/29/20
-0.0355 (-16.90%)
since 09/18/19

Most Recent Stories

More News
Cannabinoid Drugs Market Insight, Synthesis, Drugs Analysis and Experts Outlook till 2025

is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable)....

ABT : 106.86 (+0.19%)
ACNNF : 0.1120 (unch)
CNBX : 0.1745 (+1.69%)
IDEV : 55.18 (-0.72%)
VRX.TO : 30.80 (-3.33%)
ZYNE : 3.70 (-2.63%)
Cannabics Pharmaceuticals to Establish a Division for its Antitumor Drug Candidate RCC-33

, Israel and BETHESDA, , /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it is...

CNBX : 0.1745 (+1.69%)
Cannabics Pharmaceuticals to Establish a Division for its Antitumor Drug Candidate RCC-33

TEL AVIV , Israel and BETHESDA, Maryland , Aug. 20, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its...

CNBX : 0.1745 (+1.69%)
Cannabics Pharmaceuticals Appoints Dr. Dana Ben-Ami Shor (MD), Gastroenterologist, to its Scientific Board of Advisors

, Israel and BETHESDA, Md., /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it...

CNBX : 0.1745 (+1.69%)
Cannabics Pharmaceuticals Appoints Dr. Dana Ben-Ami Shor (MD), Gastroenterologist, to its Scientific Board of Advisors

TEL AVIV , Israel and BETHESDA, Md., Aug. 5, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects,...

CNBX : 0.1745 (+1.69%)
Cannabics Pharmaceuticals Appoints Dr. Erez Scapa, MD to its Scientific Board of Advisors

, Israel and BETHESDA, , /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has...

CNBX : 0.1745 (+1.69%)
Cannabics Pharmaceuticals Appoints Dr. Erez Scapa, MD to its Scientific Board of Advisors

TEL AVIV , Israel and BETHESDA, Maryland , June 16, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its...

CNBX : 0.1745 (+1.69%)
Cannabics Pharmaceuticals and Cannomed Collaborate to Develop Cannabis Strains Targeting Cancers

, Israel and BETHESDA, Maryland, /PRNewswire/ --  (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has signed a Memorandum...

CNMD : 77.63 (-6.36%)
CNBX : 0.1745 (+1.69%)
Cannabics Pharmaceuticals and Cannomed Collaborate to Develop Cannabis Strains Targeting Cancers

TEL AVIV , Israel and BETHESDA, Maryland, June 10, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc.  (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer...

CNBX : 0.1745 (+1.69%)
Cannabics Pharmaceuticals to Capitalize on Israel's Final Approval for the Export of Medical Cannabis

and , /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that the Israeli government has...

CNBX : 0.1745 (+1.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CNBX with:

Key Turning Points

2nd Resistance Point 0.1839
1st Resistance Point 0.1778
Last Price 0.1745
1st Support Level 0.1677
2nd Support Level 0.1637

See More

52-Week High 0.6100
Fibonacci 61.8% 0.4022
Fibonacci 50% 0.3380
Fibonacci 38.2% 0.2738
Last Price 0.1745
52-Week Low 0.0660

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar